tradingkey.logo

Galapagos presented new data at ICML 2025 from Cohort 3 of ATALANTA-1 in relapsed/refractory indolent NHL patients

ReutersJun 18, 2025 9:44 PM

- Galapagos NV GLPG.AS:

  • GALAPAGOS PRESENTED NEW DATA AT ICML 2025 FROM COHORT 3 OF ATALANTA-1 IN RELAPSED/REFRACTORY INDOLENT NHL PATIENTS, DEMONSTRATING HIGH COMPLETE RESPONSE AND MRD NEGATIVITY RATES WITH CAR-T CANDIDATE GLPG5101

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI